Overview

Clinilabs is a global, full-service CRO dedicated to providing a full range of CNS drug development services to pharmaceutical and biotechnology companies, from first-in-human to Phase 3 trials.

Research Experience

Clinilabs Drug Development Corporation is the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development. With deep expertise in CNS, we are committed to the development of medicines that treat a range of psychiatric, neurological and substance use disorders, as well as rare and ultra-rare CNS diseases. Clinilabs partners with pharmaceutical and biotechnology companies to deliver a complete, first-in-human to Phase 3 spectrum of high quality, timely, and cost-effective clinical drug development services, with the shared goal of speeding new CNS medicines to market.

We are process-driven yet structured to be nimble, providing personalized service that meets the needs of customers and projects of all sizes. Clinilabs has conducted more than 675 CNS clinical trials in our 21-year history and played a pivotal role in the approval of 19 new therapies across 10 CNS indications to help transform the lives of patients worldwide.

Facility Description

Our headquarter offices are in New Jersey and are supported by teams in major global hubs including New York City, San Diego, Beijing, Paris and Tokyo.

Investigator Experience

Clinilabs Drug Development Corporation works with investigators worldwide to conduct multicenter clinical trials. We identify investigators based on their experience, as well as their ability to recruit patient populations of interest to our sponsors.

Patient Demographics

Our active database consists of over 57,000 potential study candidates from the New York / New Jersey metro area which is expanding daily through social media marketing, traditional media placements, community outreach, and online patient education in the form of videos, webinars, and podcasts.